SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nataliya Razumilava, Gregory J Gores, Cholangiocarcinoma, The Lancet, 2014, 383, 9935, 2168

    CrossRef

  2. 2
    Xiaodan Zhang, William S. Harmsen, Teresa A. Mettler, W. Ray Kim, Rosebud O. Roberts, Terry M. Therneau, Lewis R. Roberts, Roongruedee Chaiteerakij, Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes, Hepatology, 2014, 60,
  3. 3
    Sudhakar K. Venkatesh, Vishal Chandan, Lewis R. Roberts, Liver Masses: A Clinical, Radiologic, and Pathologic Perspective, Clinical Gastroenterology and Hepatology, 2014, 12, 9, 1414

    CrossRef

  4. 4
    Jun-Shan Li, Tian-Jie Han, Nie Jing, Lei Li, Xiao-Hua Zhang, Feng-Zhen Ma, Ji-Yong Liu, Obesity and the risk of cholangiocarcinoma: a meta-analysis, Tumor Biology, 2014, 35, 7, 6831

    CrossRef

  5. 5
    Tetsuji Fujita, Analyzing risk factors for intrahepatic cholangiocarcinoma, Hepatology, 2013, 58, 5
  6. 6
    Laurent Sulpice, Michel Rayar, Mireille Desille, Bruno Turlin, Alain Fautrel, Eveline Boucher, Francisco Llamas-Gutierrez, Bernard Meunier, Karim Boudjema, Bruno Clément, Cédric Coulouarn, Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma, Hepatology, 2013, 58, 6